CTOs on the Move


 
Emocha uses video technology and human engagement to empower patients to take every dose of medication as prescribed. emocha facilitates a daily touchpoint for patients in order to expand access to treatment, extend the reach of existing care teams, and retain patients in care. emocha`s turnkey, enterprise adherence solution operates through dose-by-dose observation and clinical assessment of potential administration problems, including technique and side effects. Coupled with daily engagement, support, and incentives, emocha is the first holistic solution to medication non-adherence.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.emocha.com
  • 916 North Charles Street 2120, 12nd Floor - Suite 200
    Baltimore, MD USA 21221
  • Phone: 410.864.8587

Executives

Name Title Contact Details
Ramon Castro
Chief Technology Officer Profile
Gorkem Sevinc
Chief Technology Officer and Co-Founder Profile

Similar Companies

Prairie Senior Cottages

Prairie Senior Cottages is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GandH Wire Company

G&H Wire Company is a Greenwood, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lets Talk Spech Language Svcs

Lets Talk Spech Language Svcs is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Santera Rehabilitation Inc

Santera Rehabilitation Inc is a Bristol, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delphinus Medical Technologies

Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.